Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial source : Www.inventivapharma.com save search
Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis
Published: 2023-01-04 (Crawled : 21:00) - inventivapharma.com
IVA | $3.45 7.14% 1.83% 12K
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: -7.84%
cirrhosis trial nash
Inventiva announces the screening of the first patient in LEGEND, a Phase IIa combination trial with lanifibranor and empagliflozin in patients with NASH and T2D
Published: 2022-07-07 (Crawled : 21:00) - inventivapharma.com
IVA | $3.45 7.14% 1.83% 12K
|
Health Technology
|
| O: 5.35%
H: 4.2%
C: 4.2%
trial nash
Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA
Published: 2022-03-08 (Crawled : 07:00) - inventivapharma.com
IVA | $3.45 7.14% 1.83% 12K
|
Health Technology
|
| O: -0.18%
H: 2.55%
C: 1.91%
fda application ces trial nash
Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes
Published: 2021-10-27 (Crawled : 20:00) - inventivapharma.com
IVA | $3.45 7.14% 1.83% 12K
|
Health Technology
|
| O: -1.03%
H: 1.25%
C: 0.24%
diabetes nash trial designation
Inventiva announces the initiation of its pivotal Phase III clinical trial evaluating lanifibranor in NASH
Published: 2021-09-08 (Crawled : 20:00) - inventivapharma.com
IVA | $3.45 7.14% 1.83% 12K
|
Health Technology
|
| O: -0.87%
H: 2.64%
C: 1.25%
nash trial
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.